首页良性前列腺增生治疗及预后证据详情

Comparison of enucleation between thulium laser and holmium laser for benign prostatic hyperplasia: A systematic review and meta- analysis

原文:2022年 发布于 Asian Journal of Surgery 45卷 第2期 689-697 浏览量:1111次 原文链接
文献简介

To compare the clinical efficacy and safety of Thulium laser enucleation of prostate (ThuLEP) and Holmium laser enucleation of prostate (HoLEP). We systematically searched PubMed, Embase, and Cochrane Library databases within a period from the date of database establishment to October 2020. RevMan 5.4. was used for calculation and statistical analyses. 8 studies of 2125 patients were included. ThuLEP provided less hemoglobin decrease (MD:-0.37, 95%CI-0.61 to-0.14, P = 0.002) and shorter length of hospital stay (MD:-0.41, 95%CI-0.72 to-0.10, P = 0.01). During the postoperative follow-ups, statistically significant differences only were found in IPSS (MD:-0.96; 95%CI-1.27 to-0.65; P < 0.00001) at the 3rd month. In conclusion, our study demonstrates that ThuLEP, compared with HoLEP, has better security, faster improvement of symptoms. However, our conclusions still require a larger sample size, multi-center, and longer follow-up randomized controlled trials to verify. (c) 2021 Asian Surgical Association and Taiwan Robotic Surgery Association. Publishing services by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/ licenses/by-nc-nd/4.0/).

热门文献